Mortalin–p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy

: Hyaluronan (HA) is a natural linear polysaccharide that has excellent hydrophilicity, biocompatibility, biodegradability, and low immunogenicity, making it one of the most attractive biopolymers used for biomedical researches and applications. Due to the multiple functional sites on HA and its intrinsic affinity for CD44, a receptor highly expressed on various cancer cells, HA has been widely engineered to construct different drug-loading nanoparticles (NPs) for CD44- targeted anti-tumor therapy. When a cocktail of drugs is co-loaded in HA NP, a multifunctional nano-carriers could be obtained, which features as a highly effective and self-targeting strategy to combat the cancers with CD44 overexpression. The HA-based multidrug nano-carriers can be a combination of different drugs, various therapeutic modalities, or the integration of therapy and diagnostics (theranostics). Up to now, there are many types of HA-based multidrug nano-carriers constructed by different formulation strategies including drug co-conjugates, micelles, nano-gels and hybrid NP of HA and so on. This multidrug nano-carrier takes the full advantages of HA as NP matrix, drug carriers and targeting ligand, representing a simplified and biocompatible platform to realize the targeted and synergistic combination therapy against the cancers. In this review, recent progresses about HA-based multidrug nano-carriers for combination cancer therapy are summarized and its potential challenges for translational applications have been discussed.

Download Full-text

An artificial cell system for biocompatible gene delivery in cancer therapy

Nanoscale ◽

10.1039/c9nr09131a ◽

2020 ◽

Vol 12 (18) ◽

pp. 10189-10195 ◽

Cited By ~ 7

Author(s):

Xin Zhao ◽

Dongyang Tang ◽

Ying Wu ◽

Shaoqing Chen ◽

Cheng Wang

Keyword(s):

Gene Therapy ◽

Cancer Therapy ◽

Gene Delivery ◽

Cancer Cells ◽

Cell System ◽

Artificial Cell

The artifical cell system for the gene therapy of cancer might be a promising approach for the reversal of neoplastic progress of cancer cells.

Download Full-text

Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy

Redox Biology ◽

10.1016/j.redox.2021.101864 ◽

2021 ◽

pp. 101864

Author(s):

M.S. Petronek ◽

J.M. Stolwijk ◽

S.D. Murray ◽

E.J. Steinbach ◽

Y. Zakharia ◽

...

Keyword(s):

Cancer Therapy ◽

Small Molecules ◽

Cancer Cells ◽

Therapeutic Window

Download Full-text

Nuclear Transglutaminase 2 interacts with topoisomerase II⍺ to promote DNA damage repair in lung cancer cells

Journal of Experimental & Clinical Cancer Research ◽

10.1186/s13046-021-02009-2 ◽

2021 ◽

Vol 40 (1) ◽

Author(s):

Xiao Lei ◽

Kun Cao ◽

Yuanyuan Chen ◽

Hui Shen ◽

Zhe Liu ◽

...

Keyword(s):

Lung Cancer ◽

Dna Damage ◽

Cancer Therapy ◽

Cancer Cells ◽

Protein Localization ◽

Transglutaminase 2 ◽

Lung Cancer Cells ◽

Mass Spectrometry Analysis ◽

Cancer Resistance ◽

Dsb Repair

Abstract Background To block repairs of DNA damages, especially the DNA double strand break (DSB) repair, can be used to induce cancer cell death. DSB repair depends on a sequential activation of DNA repair factors that may be potentially targeted for clinical cancer therapy. Up to now, many protein components of DSB repair complex remain unclear or poorly characterized. In this study, we discovered that Transglutaminase 2 (TG2) acted as a new component of DSB repair complex. Methods A bioinformatic analysis was performed to identify DNA damage relative genes from dataset from The Cancer Genome Atlas. Immunofluorescence and confocal microscopy were used to monitor the protein localization and recruitment kinetics. Furthermore, immunoprecipitation and mass spectrometry analysis were performed to determine protein interaction of both full-length and fragments or mutants in distinct domain. In situ lung cancer model was used to study the effects cancer therapy in vivo. Results After DSB induction, cytoplasmic TG2 was extensively mobilized and translocated into nucleus after phosphorylated at T162 site by DNA-PKcs. Nuclear TG2 quickly accumulated at DSB sites and directly interacting with Topoisomerase IIα (TOPOIIα) with its TGase domain to promote DSB repair. TG2 deficient cells lost capacity of DSB repair and become susceptible to ionizing radiation. Specific inhibition of TG2-TOPOIIα interaction by glucosamine also significantly inhibited DSB repair, which increased sensitivity in lung cancer cells and engrafted lung cancers. Conclusions These findings elucidate new mechanism of TG2 in DSB repair trough directly interacting with TOPOIIα, inhibition of which provided potential target for overcoming cancer resistance.

Download Full-text

Magneto Mitochondrial Dysfunction Mediated Cancer Cell Death Using Intracellular Magnetic Nano-Transducers

Biomaterials Science ◽

10.1039/d1bm00419k ◽

2021 ◽

Author(s):

Wooram Park ◽

Seok-Jo Kim ◽

Paul Cheresh ◽

Jeanho Yun ◽

Byeongdu Lee ◽

...

Keyword(s):

Cell Death ◽

Cancer Therapy ◽

Mitochondrial Dysfunction ◽

Cancer Cells ◽

Cancer Cell ◽

High Sensitivity ◽

Intrinsic Pathway ◽

Cancer Cell Death

Mitochondria are crucial regulators of the intrinsic pathway of cancer cell death. The high sensitivity of cancer cells to mitochondrial dysfunction offers opportunities for emerging targets in cancer therapy. Herein,...

Download Full-text

Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins

Cancers ◽

10.3390/cancers13061201 ◽

2021 ◽

Vol 13 (6) ◽

pp. 1201

Author(s):

Garri Manasaryan ◽

Dmitry Suplatov ◽

Sergey Pushkarev ◽

Viktor Drobot ◽

Alexander Kuimov ◽

...

Keyword(s):

Molecular Modeling ◽

Cancer Therapy ◽

Adverse Effects ◽

Binding Site ◽

Cancer Cells ◽

Anticancer Drugs ◽

Bioinformatic Analysis ◽

Parp Inhibitors ◽

Functional Region ◽

D Loop

The PARP family consists of 17 members with diverse functions, including those related to cancer cells’ viability. Several PARP inhibitors are of great interest as innovative anticancer drugs, but they have low selectivity towards distinct PARP family members and exert serious adverse effects. We describe a family-wide study of the nicotinamide (NA) binding site, an important functional region in the PARP structure, using comparative bioinformatic analysis and molecular modeling. Mutations in the NA site and D-loop mobility around the NA site were identified as factors that can guide the design of selective PARP inhibitors. Our findings are of particular importance for the development of novel tankyrase (PARPs 5a and 5b) inhibitors for cancer therapy.

Download Full-text

Biocompatible hole scavenger–assisted graphene oxide dots for photodynamic cancer therapy

Nanoscale ◽

10.1039/d1nr01476e ◽

2021 ◽

Author(s):

Chun-Yan Shih ◽

Wei-Lun Huang ◽

I-Ting Chiang ◽

Wu-Chou Su ◽

Hsisheng Teng

Keyword(s):

Ascorbic Acid ◽

Graphene Oxide ◽

Cancer Therapy ◽

Cancer Cells ◽

Nitrogen Doped ◽

Photodynamic Cancer Therapy ◽

Hole Scavenger ◽

Nitrogen Doped Graphene ◽

Doped Graphene

Tuning of the nitrogen-doped graphene oxide dot and ascorbic acid concentrations can selectively kill cancer cells through either apoptosis or necrosis.

Download Full-text

Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress

Anti-Cancer Agents in Medicinal Chemistry ◽

10.2174/187152011795255902 ◽

2011 ◽

Vol 11 (2) ◽

pp. 213-221 ◽

Cited By ~ 41

Author(s):

Julien Verrax ◽

Raphael Beck ◽

Nicolas Dejeans ◽

Christophe Glorieux ◽

Brice Sid ◽

...

Keyword(s):

Oxidative Stress ◽

Cancer Therapy ◽

Cancer Cells ◽

Redox Active

Download Full-text

Down regulation of Pinkbar/pAKT and MMP2/MMP9 expression in MDA-MB-231 breast cancer cells as potential targets in cancer therapy by hAMSCs secretome

Cells Tissues Organs ◽

10.1159/000520370 ◽

2021 ◽

Author(s):

Termeh Shakery ◽

Fatemeh Safari

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Molecular Mechanisms ◽

Growth Factor Receptor ◽

3D Cell Culture ◽

Therapeutic Effects ◽

Down Regulation ◽

Egfr Signaling Pathway

Breast cancer (BC) is one of the most causes of cancer-related death among women worldwide. Cancer therapy based on stem cells was considered as a novel and promising platform. In present study, we explored the therapeutic effects of human amniotic mesenchymal stromal cells (hAMSCs) through Pinkbar (planar intestinal-and kidney-specific BAR domain protein), pAKT, and matrix metalloproteinases including MMP2, MMP9 on MDA-MB-231 breast cancer cells. To do so, we employed a co-culture system using 6 well plates transwell with a diameter of 0.4 μm pore sized. After 72h hAMSCs-treated MDA-MB-231 breast cancer cells, the expression of Epidermal growth factor receptor (EGFR), and c-Src (a key mediator in EGFR signaling pathway), Pinkbar, pAKT, MMP2, and MMP9 was analyzed by using quantitative real time PCR (qRT-PCR) and western blot methods. Based on using 2D and 3D cell culture models, the significant reduction of tumor cell growth and motility through down regulation of EGFR, c-Src, Pinkbar, pAKT, MMP2, and MMP9 in MDA-MB-231 breast cancer cells was shown. Also, the induction of cellular apoptosis also found. Our finding indicates that the hAMSCS secretome has therapeutic effects on cancer cells. To identify the details of the molecular mechanisms, more experiments will be required.

Download Full-text